GAIL STOTLER: Open Payments
NPI 1063651008 · JOHNSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,110 in 39 payments from 14 companies in 2025. Trend: 2023 $541 · 2024 $1,736 · 2025 $1,110
Food & beverage: $1,110
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $404 |
| Amgen Inc. | 1 | $113 |
| Lilly USA, LLC | 1 | $113 |
| Phathom Pharmaceuticals, Inc. | 4 | $100 |
| Janssen Biotech, Inc. | 4 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $67 |
| Regeneron Healthcare Solutions, Inc. | 2 | $58 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| Ardelyx, Inc. | 2 | $33 |
| Novo Nordisk Inc | 1 | $28 |
Products named: RINVOQ, SKYRIZI, REPATHA, ZEPBOUND, VOQUEZNA, TREMFYA, DUPIXENT, CREON.
Industry payments across PA — which companies pay providers there.
